Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
ESSEX BIO-TECH (01061)
- 3.140
- -0.030-0.95%
Not Open May 6 16:05 CST
1.78BMarket Cap5.60P/E (TTM)
3.170High3.100Low392.00KVolume3.170Open3.170Prev Close1.23MTurnover0.07%Turnover Ratio5.60P/E (Static)567.01MShares6.05052wk High0.74P/B1.78BFloat Cap3.06052wk Low0.13Dividend TTM567.01MShs Float8.937Historical High0.120Dividend LFY2.21%Range %-0.757Historical Low3.130Avg Price1000Lot Size4.14%Div Yield TTM3.82%Div Yield LFY
ESSEX BIO-TECH (01061) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 10.43%414.66M | 3.14%203.57M | 8.52%375.5M | -3.65%197.38M | 32.91%346.01M | 25.91%204.86M | -34.00%260.34M | -11.13%162.7M | 57.25%394.46M | 216.79%183.07M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -3.34%-11.83M | 20.88%-5.42M | 7.27%-11.45M | 2.53%-6.85M | -39.04%-12.34M | -103.06%-7.03M | 9.97%-8.88M | -11.28%-3.46M | -30.08%-9.86M | 17.41%-3.11M |
| Attributable subsidiary (profit) loss | -94.42%162.38K | -91.74%161K | 77.36%2.91M | 236.79%1.95M | 746.84%1.64M | --579K | --193.82K | ---- | ---- | ---- |
| Impairment and provisions: | 17.81%8.47M | ---- | 42.32%7.19M | --7.19M | -87.00%5.05M | ---- | --38.84M | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | --7.19M | --7.19M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --25.83M | ---- | ---- | ---- |
| -Other impairments and provisions | --8.47M | ---- | ---- | ---- | -61.19%5.05M | ---- | --13.01M | ---- | ---- | ---- |
| Revaluation surplus: | 309.99%1.95M | -99.64%23K | 92.68%-930.7K | 180.61%6.37M | -367.43%-12.72M | -328.83%-7.9M | -85.08%4.76M | 148.27%3.45M | 246.46%31.9M | 117.46%1.39M |
| -Other fair value changes | 309.99%1.95M | -99.64%23K | 92.68%-930.7K | 180.61%6.37M | -367.43%-12.72M | -328.83%-7.9M | -85.08%4.76M | 148.27%3.45M | 246.46%31.9M | 117.46%1.39M |
| Asset sale loss (gain): | -62.17%181.49K | -21.43%22K | -78.42%479.79K | -98.44%28K | 678.40%2.22M | 1,696.00%1.8M | 2.66%285.68K | 1,350.00%100K | 26.90%278.28K | -14.29%-8K |
| -Loss (gain) on sale of property, machinery and equipment | -62.17%181.49K | -21.43%22K | -78.42%479.79K | -98.44%28K | 678.40%2.22M | 1,696.00%1.8M | 2.66%285.68K | 1,350.00%100K | 26.90%278.28K | -14.29%-8K |
| Depreciation and amortization: | 12.02%62.59M | 7.47%28.46M | -6.69%55.87M | -15.17%26.48M | 42.86%59.88M | 52.31%31.22M | 27.12%41.91M | 24.85%20.5M | 19.46%32.97M | 24.44%16.42M |
| -Amortization of intangible assets | 0.29%25.33M | -0.86%12.52M | -5.19%25.25M | -9.27%12.63M | 68.92%26.64M | 90.87%13.92M | 36.66%15.77M | 31.36%7.29M | 39.49%11.54M | 55.78%5.55M |
| Financial expense | 28.38%7.82M | -18.65%2.8M | -45.71%6.09M | -63.52%3.44M | -2.27%11.21M | 102.84%9.44M | 24.37%11.47M | -13.24%4.65M | 548.97%9.22M | 58.59%5.36M |
| Exchange Loss (gain) | -382.65%-7.79M | -543.01%-10.77M | -54.96%2.76M | 231.32%2.43M | 382.18%6.12M | -206.25%-1.85M | 25.46%-2.17M | 552.73%1.74M | -342.37%-2.91M | -151.96%-385K |
| Special items | 89.85%-1.46M | 169.70%10.49M | -790.67%-14.39M | -1,919.71%-15.05M | 128.59%2.08M | 108.62%827K | -285.47%-7.29M | -496.82%-9.6M | 247.31%3.93M | 25.74%2.42M |
| Operating profit before the change of operating capital | 11.96%474.75M | 2.67%229.33M | 3.63%424.03M | -3.69%223.37M | 20.53%409.16M | 28.79%231.93M | -26.20%339.47M | -12.22%180.09M | 73.66%459.98M | 203.93%205.16M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -716.74%-18.35M | -1,530.71%-4.57M | -113.38%-2.25M | -102.42%-280K | 76.87%16.79M | -18.53%11.58M | 9.31%9.49M | 170.32%14.21M | 121.65%8.68M | -99.74%-20.21M |
| Accounts receivable (increase)decrease | -770.77%-86.82M | 2.62%-61.8M | 109.82%12.94M | 61.13%-63.46M | -165.66%-131.75M | -202.78%-163.27M | 218.60%200.64M | 404.96%158.86M | -185.80%-169.17M | -130.82%-52.09M |
| Accounts payable increase (decrease) | -61.99%6.49M | -363.59%-24.56M | -75.90%17.08M | -85.31%9.32M | 167.17%70.9M | 161.02%63.42M | -231.00%-105.56M | -304.19%-103.92M | 223.94%80.58M | 137.25%50.89M |
| prepayments (increase)decrease | 103.12%656.89K | 184.05%5.98M | -177.86%-21.06M | -166.35%-7.11M | 37.15%-7.58M | -747.82%-2.67M | -161.66%-12.06M | -97.45%412K | 236.37%19.56M | 4,492.12%16.16M |
| Cash from business operations | -12.54%376.73M | -10.78%144.38M | 20.48%430.75M | 14.79%161.83M | -17.24%357.52M | -43.53%140.98M | 8.10%431.99M | 24.87%249.64M | 16.65%399.64M | 123.62%199.92M |
| Other taxs | -13.06%-70.41M | 27.43%-21.89M | -240.03%-62.28M | -315.06%-30.17M | 62.77%-18.32M | 172.87%14.03M | -616.53%-49.2M | -294.27%-19.25M | 121.98%9.53M | 131.39%9.91M |
| Net cash from operations | -16.87%306.32M | -6.97%122.49M | 8.63%368.47M | -15.06%131.66M | -11.39%339.21M | -32.72%155.01M | -6.45%382.79M | 9.80%230.39M | 36.73%409.16M | 262.84%209.82M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 8.56%10.42M | -24.69%4.47M | -9.54%9.59M | -3.60%5.94M | 56.77%10.61M | 154.25%6.16M | -0.45%6.77M | 49.35%2.42M | 26.53%6.8M | -42.51%1.62M |
| Restricted cash (increase) decrease | ---- | ---- | -93.07%3.35M | 107.57%3.35M | 188.83%48.34M | ---44.25M | ---54.42M | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---3.13M | ---3.14M | ---- | ---- | 39.22%-9.91M | 86.37%-2.06M | 40.34%-16.31M | 8.55%-15.14M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | -62.39%14.28M | -75.60%6.78M | 394.18%37.96M | 735.25%27.77M | -435.16%-12.9M | 72.73%3.33M |
| Sale of fixed assets | -90.48%71.05K | -60.81%183K | 606.19%746.05K | 46,600.00%467K | 74.52%105.64K | 0.00%1K | -53.14%60.54K | -99.13%1K | 416.24%129.17K | -22.30%115K |
| Purchase of fixed assets | -142.14%-107.51M | -648.48%-70.91M | -111.10%-44.4M | -86.35%-9.47M | 76.50%-21.03M | 90.88%-5.08M | 0.61%-89.49M | -67.94%-55.76M | 7.27%-90.05M | -1.60%-33.2M |
| Purchase of intangible assets | 10.62%-67.1M | -11.29%-44.85M | 29.84%-75.07M | 40.68%-40.3M | 44.67%-107.01M | 43.13%-67.94M | -17.33%-193.42M | -63.10%-119.46M | 29.20%-164.85M | -58.43%-73.25M |
| Acquisition of subsidiaries | ---1.05M | ---- | ---- | ---- | ---- | ---- | 10,901.77%3.47M | --3.47M | 101.45%31.56K | ---- |
| Recovery of cash from investments | ---- | ---- | -16.49%4.49M | 126.10%4.49M | --5.37M | --1.99M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | 56.78%-2.16M | 51.45%-2.16M | -64.18%-5M | ---4.45M | -3.73%-3.05M | ---- | -112.97%-2.94M | -112.91%-2.94M |
| Net cash from investment operations | -54.96%-165.17M | -172.15%-111.1M | -96.16%-106.59M | 61.77%-40.82M | 82.01%-54.34M | 25.64%-106.8M | -7.84%-302.03M | -20.22%-143.62M | 18.41%-280.08M | -34.85%-119.46M |
| Net cash before financing | -46.10%141.15M | -87.47%11.38M | -8.07%261.88M | 88.44%90.84M | 252.75%284.87M | -44.45%48.21M | -37.44%80.76M | -3.97%86.78M | 393.17%129.08M | 393.76%90.36M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 118.78%233.87M | 169.25%124.35M | 150.09%106.9M | --46.18M | --42.74M | ---- | ---- | ---- | -73.97%55.45M | --15.45M |
| Refund | 53.71%-82.44M | -156.85%-25.95M | 36.62%-178.1M | 75.37%-10.1M | -244.36%-280.99M | 16.61%-41.02M | -48.02%-81.6M | -195.87%-49.19M | -186.36%-55.13M | -72.73%-16.63M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.89M | --1.89M |
| Interest paid - financing | 86.96%-8.29M | 5.27%-2.97M | -299.49%-63.62M | 72.42%-3.13M | -1.62%-15.92M | -71.95%-11.35M | -27.35%-15.67M | -8.91%-6.6M | -42.48%-12.31M | -44.29%-6.06M |
| Dividends paid - financing | -23.71%-73.71M | -33.21%-34.02M | -49.25%-59.58M | -79.02%-25.54M | 26.78%-39.92M | 54.87%-14.27M | -5.08%-54.53M | -9.67%-31.61M | -79.57%-51.89M | 0.25%-28.82M |
| Issuance expenses and redemption of securities expenses | 71.25%-325.27K | -203.74%-325K | 91.01%-1.13M | 97.09%-107K | 14.85%-12.59M | 37.38%-3.68M | -70.35%-14.79M | -156.79%-5.88M | -98.32%-8.68M | ---2.29M |
| Net cash from financing operations | 130.92%62.1M | 891.28%58.97M | 35.21%-200.81M | 108.31%5.95M | -83.27%-309.92M | 24.28%-71.62M | -131.24%-169.11M | -150.98%-94.59M | -148.92%-73.13M | 14.26%-37.69M |
| Effect of rate | 262.38%22.32M | 258.30%13.01M | -60.14%-13.75M | 42.73%-8.22M | 78.27%-8.58M | 35.89%-14.35M | -353.02%-39.49M | -522.48%-22.39M | -25.61%15.61M | 164.32%5.3M |
| Net Cash | 232.83%203.25M | -27.31%70.35M | 343.70%61.07M | 513.42%96.79M | 71.64%-25.06M | -199.65%-23.41M | -257.93%-88.36M | -114.83%-7.81M | -46.95%55.94M | 170.50%52.67M |
| Begining period cash | 9.28%557.17M | 9.28%557.17M | -6.19%509.85M | -6.19%509.85M | -19.04%543.49M | -19.04%543.49M | 11.93%671.34M | 11.93%671.34M | 26.71%599.78M | 26.71%599.78M |
| Cash at the end | 40.48%782.73M | 7.04%640.53M | 9.28%557.17M | 18.33%598.41M | -6.19%509.85M | -21.12%505.72M | -19.04%543.49M | -2.53%641.14M | 11.93%671.34M | 68.49%657.75M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 32.87%408.73M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"